Oppenheimer & Co’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $546K | Sell |
99,825
-612
| -0.6% | -$3.35K | 0.01% | 1108 |
|
2025
Q1 | $632K | Buy |
100,437
+19,034
| +23% | +$120K | 0.01% | 997 |
|
2024
Q4 | $335K | Sell |
81,403
-544
| -0.7% | -$2.24K | 0.01% | 1212 |
|
2024
Q3 | $274K | Buy |
81,947
+21,128
| +35% | +$70.6K | ﹤0.01% | 1285 |
|
2024
Q2 | $181K | Buy |
60,819
+404
| +0.7% | +$1.2K | ﹤0.01% | 1349 |
|
2024
Q1 | $208K | Buy |
+60,415
| New | +$208K | ﹤0.01% | 1328 |
|